[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA975168B - Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments - Google Patents

Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments

Info

Publication number
ZA975168B
ZA975168B ZA975168A ZA975168A ZA975168B ZA 975168 B ZA975168 B ZA 975168B ZA 975168 A ZA975168 A ZA 975168A ZA 975168 A ZA975168 A ZA 975168A ZA 975168 B ZA975168 B ZA 975168B
Authority
ZA
South Africa
Prior art keywords
trimegestone
medicaments
preparation process
devices intended
transdermic administration
Prior art date
Application number
ZA975168A
Inventor
Jean-Luc Dubois
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA975168B publication Critical patent/ZA975168B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
ZA975168A 1996-06-11 1997-06-11 Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments ZA975168B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607208A FR2749586B1 (en) 1996-06-11 1996-06-11 NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS

Publications (1)

Publication Number Publication Date
ZA975168B true ZA975168B (en) 1998-07-22

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975168A ZA975168B (en) 1996-06-11 1997-06-11 Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments

Country Status (23)

Country Link
EP (1) EP0906127B1 (en)
JP (1) JP2000514416A (en)
CN (1) CN1110327C (en)
AR (1) AR013580A1 (en)
AT (1) ATE216269T1 (en)
AU (1) AU717335B2 (en)
BR (1) BR9709690A (en)
CA (1) CA2257902A1 (en)
CZ (1) CZ295227B6 (en)
DE (1) DE69712057T2 (en)
DK (1) DK0906127T3 (en)
ES (1) ES2173453T3 (en)
FR (1) FR2749586B1 (en)
HU (1) HU225034B1 (en)
IL (1) IL127281A0 (en)
NO (1) NO315149B1 (en)
PL (1) PL189533B1 (en)
PT (1) PT906127E (en)
RU (1) RU2204417C2 (en)
TR (1) TR199802578T2 (en)
TW (1) TW474826B (en)
WO (1) WO1997047333A1 (en)
ZA (1) ZA975168B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (en) * 1998-08-27 2001-09-14 Oreal AEROSOL DEVICE CONTAINING A POLYCONDENSATE COMPRISING AT LEAST ONE POLYURETHANE AND / OR POLYUREA PATTERN
ITMI20020798A1 (en) * 2002-04-15 2003-10-15 F T Holding S A SILICONE ADHESIVE MATERIAL TRANSDERMAL PATCHES STABILIZED WITH METHACRYLIC COPOLYMERS
GEP20084561B (en) * 2003-10-28 2008-12-10 Noven Pharma System and method for controlled drug release and transdermal drug delivery device
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch
JP2006230930A (en) * 2005-02-28 2006-09-07 Alcare Co Ltd Pasting material
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (en) * 1978-07-13 1980-02-08 Roussel Uclaf NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Also Published As

Publication number Publication date
DK0906127T3 (en) 2002-08-05
HU225034B1 (en) 2006-05-29
IL127281A0 (en) 1999-09-22
JP2000514416A (en) 2000-10-31
TW474826B (en) 2002-02-01
PL189533B1 (en) 2005-08-31
EP0906127A1 (en) 1999-04-07
ATE216269T1 (en) 2002-05-15
PL330535A1 (en) 1999-05-24
NO985791D0 (en) 1998-12-10
WO1997047333A1 (en) 1997-12-18
HUP9903340A3 (en) 2000-04-28
NO985791L (en) 1999-02-11
HUP9903340A2 (en) 2000-03-28
CZ295227B6 (en) 2005-06-15
PT906127E (en) 2002-09-30
ES2173453T3 (en) 2002-10-16
NO315149B1 (en) 2003-07-21
CA2257902A1 (en) 1997-12-18
RU2204417C2 (en) 2003-05-20
DE69712057D1 (en) 2002-05-23
AU717335B2 (en) 2000-03-23
DE69712057T2 (en) 2002-10-02
CN1110327C (en) 2003-06-04
CN1227503A (en) 1999-09-01
FR2749586A1 (en) 1997-12-12
AU3266097A (en) 1998-01-07
AR013580A1 (en) 2001-01-10
BR9709690A (en) 1999-08-10
TR199802578T2 (en) 1999-03-22
EP0906127B1 (en) 2002-04-17
FR2749586B1 (en) 1998-08-07
CZ410798A3 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
HUP0100136A3 (en) 11-or 17-substituted estratriols, process for their preparation, use of them and pharmaceutical compositions containing the same
IL129315A0 (en) Oxadiazoles process for their preparation and their use as medicaments
IL102591A0 (en) Compositions for the sustained and controlled release of medicaments and their preparation
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
GB2301537B (en) Two-component device for the administration of drugs
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL128601A0 (en) 7alpha-(epsilon-aminoalkyl) estratrienes, process for preparing the same, pharmaceutical preparation containing said 7alpha-(epsilon-aminoalkyl) estratrienes and their use for preparing medicaments
KR100206481B1 (en) Galenic form for ocular administration and process for the preparation of same
HRP970450B1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or diagnostic agents and drugs containing them
IL119552A0 (en) Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
ZA9557B (en) Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
AU5326598A (en) New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
IL164513A0 (en) Pyrazolopyrimidines, pharmaceutical compositions containing them, and their use in the preparation of medicaments
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
AU4081393A (en) Medicaments for the treatment of anxiety
ZA945892B (en) Microparticles processes for their preparation and their use for the preparation of medicaments
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL115981A (en) Cyclolignan derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis